The de‐regulated NF‐κB signalling in cancers is widely linked to tumour progression, recurrence, poor survival, aggressiveness and chemoresistance, while the current study reinforces the notion that NF‐κB plays both pro‐oncogenic and anti‐oncogenic roles.6, 70. Here, NFKB1 is linked to cancer.